Sonio Detect, an FDA 510(k) cleared AI assistant, leverages deep learning networks to ensure higher image quality in real-time and improve the quality of care through greater clinical accuracy. Together with Sonio’s AI expertise, Samsung Medison’s leading-edge ultrasound systems will help bring to market breakthrough AI-enhanced workflows and accelerate innovation in patient outcomes and quality of prenatal care. Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology,” said Yong Kwan Kim, Samsung Medison CEO. “Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”“Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides,” said Cécile Brosset, Sonio CEO. “We have found in Samsung Medison an amazing, trusting partner to pursue and accelerate our roadmap and mission.
